Left ventricular hypertrophy reclassification and death: Application of the Recommendation of the American Society of Echocardiography/ European Association of Echocardiography

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 1, 2012, Pages 109-117

  Barbieri, Andrea ^a   Bursi, Francesca ^a   Mantovani, Francesca ^a   Valenti, Chiara ^a   Quaglia, Michele ^a   Berti, Elena ^b   Marino, Massimiliano ^b   Modena, Maria Grazia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Healthcare and Social Agency   (Italy)

Author keywords

Indexed left ventricular mass; Left ventricular hypertrophy; Prognosis; Septal wall thickness

Indexed keywords

ADULT; ARTICLE; DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL;

EID: 84863838826     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ejechocard/jer176     Document Type: Article

References (31)

1. Devereux RB, Casale PN, Kligfield P, Eisenberg RR, Miller D, Campo E et al. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986;57:1388-93. (Pubitemid 16055293)
2. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
3. Ilercil A, O'Grady MJ, Roman MJ, Paranicas M, Lee ET, Welty TK et al. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. J Am Soc Echocardiogr 2001;14:601-11. (Pubitemid 33096475)
4. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8. (Pubitemid 8066109)
5. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8. (Pubitemid 16119719)
6. Beller GA, Bonow RO, Fuster V. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). J Am Coll Cardiol 2008;51:335-8.
7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
8. Ujino K, Barnes ME, Cha SS, Langins AP, Bailey KR, Seward JB et al. Two-dimensional echocardiographic methods for assessment of left atrial volume. Am J Cardiol 2006;98:1185-8. (Pubitemid 44584092)
9. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202. (Pubitemid 36068707)
10. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
11. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
12. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
13. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000;35:6-12. (Pubitemid 30054229)
14. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987;75:I26-33.
15. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 1991;18:1287-94.
16. Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW et al. Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005;112:819-27. (Pubitemid 41170067)
17. Drazner MH. The progression of hypertensive heart disease. Circulation 2011;123: 327-34.
18. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Wood EA, Howard BV et al. Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 1997;10:619-28. (Pubitemid 27293477)
19. Knoll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF et al. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Eur J Heart Fail 2011;13:811-9.
20. Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Pickering TG, Schwartz JE et al. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects. Am Heart J 2007;154:79 e9-15.
21. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med 1992;152:1001-4.
22. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;52:559-66.
23. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. (Pubitemid 20176696)
24. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 1997;96:1863-73. (Pubitemid 27400746)
25. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 2003;42: 1199-205. (Pubitemid 37188341)
26. Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol 2001;87: 1051-7. (Pubitemid 32710318)
27. Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 1994;73:1-5. (Pubitemid 24019991)
28. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990;65:441-5. (Pubitemid 20050523)
29. Stevens SM, Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging 2009;2:11-20.
30. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging 2008;1:582-91.
31. Quinones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC, Shindler DM et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 2000;35:1237-44. (Pubitemid 30206899)